Group One Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,573
| Closed | -$69.6K | – | 8527 |
|
|
2023
Q1 | $69.6K | Sell |
16,573
-9,884
| -37% | -$51.3K | ﹤0.01% | 4588 |
|
|
2022
Q4 | $159K | Sell |
26,457
-37,394
| -59% | -$204K | ﹤0.01% | 4047 |
|
|
2022
Q3 | $372K | Sell |
63,851
-98,584
| -61% | -$614K | ﹤0.01% | 3519 |
|
|
2022
Q2 | $970K | Buy |
162,435
+35,880
| +28% | +$184K | ﹤0.01% | 2787 |
|
|
2022
Q1 | $591K | Sell |
126,555
-201,690
| -61% | -$602K | ﹤0.01% | 3637 |
|
|
2021
Q4 | $814K | Buy |
328,245
+289,750
| +753% | +$709K | ﹤0.01% | 3567 |
|
|
2021
Q3 | $114K | Buy |
+38,495
| New | +$105K | ﹤0.01% | 5783 |
|
|
2020
Q4 | – | Sell |
-32,852
| Closed | -$109K | – | 7372 |
|
|
2020
Q3 | $71K | Buy |
32,852
+23,100
| +237% | +$29.5K | ﹤0.01% | 4419 |
|
|
2020
Q2 | $11K | Buy |
+9,752
| New | +$10.3K | ﹤0.01% | 5110 |
|
|
2019
Q2 | – | Sell |
-13,957
| Closed | -$14K | – | 5764 |
|
|
2019
Q1 | $14K | Buy |
13,957
+3,800
| +37% | +$4K | ﹤0.01% | 4176 |
|
|
2018
Q4 | $7K | Buy |
10,157
+2,750
| +37% | +$4.52K | ﹤0.01% | 4412 |
|
|
2018
Q3 | $16K | Buy |
+7,407
| New | +$18.3K | ﹤0.01% | 4485 |
|
|
2016
Q4 | – | Sell |
-1,039
| Closed | -$4K | – | 5249 |
|
|
2016
Q3 | $4K | Hold |
1,039
| – | – | ﹤0.01% | 4278 |
|
|
2016
Q2 | $4K | Sell |
1,039
-10
| -1% | -$46 | ﹤0.01% | 4351 |
|
|
2016
Q1 | $6K | Sell |
1,049
-744
| -41% | -$5.95K | ﹤0.01% | 4188 |
|
|
2015
Q4 | $22K | Buy |
1,793
+530
| +42% | +$7.08K | ﹤0.01% | 3884 |
|
|
2015
Q3 | $18K | Buy |
1,263
+357
| +39% | +$6.17K | ﹤0.01% | 4098 |
|
|
2015
Q2 | $18K | Sell |
906
-4,712
| -84% | -$90.9K | ﹤0.01% | 4091 |
|
|
2015
Q1 | $102K | Buy |
5,618
+5,516
| +5,408% | +$124K | ﹤0.01% | 2895 |
|
|
2014
Q4 | $2K | Buy |
+102
| New | +$2.36K | ﹤0.01% | 4748 |
|
|
2014
Q2 | – | Sell |
-13,518
| Closed | -$406K | – | 5920 |
|
|
2014
Q1 | $460K | Buy |
13,518
+10,196
| +307% | +$348K | 0.01% | 1703 |
|
|
2013
Q4 | $64K | Sell |
3,322
-6,572
| -66% | -$120K | ﹤0.01% | 3414 |
|
|
2013
Q3 | $162K | Buy |
9,894
+8,520
| +620% | +$98.7K | ﹤0.01% | 2569 |
|
|
2013
Q2 | $14K | Buy |
+1,374
| New | +$16.1K | ﹤0.01% | 4312 |
|
Other funds holding CTIC
Group One Trading's CTIC Position: Q2 2023 in Review
Group One Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 16,573 shares — an estimated $69.6K sold.
Group One Trading first reported a position in CTIC in Q2 2013 and held it in 24 quarters. The position peaked at $970K in Q2 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Group One Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 16,573 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $69.6K.
- Group One Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 24 quarters.
- Group One Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $970K in Q2 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.